These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30906425)

  • 1. Predictive Value Positive of MTM Eligibility Criteria under MMA and ACA in Identifying Individuals with Medication Utilization Issues.
    Qiao Y; Spivey CA; Wang J; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Pharm Health Serv Res; 2018 Dec; 9(4):393-401. PubMed ID: 30906425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Medication Therapy Management Eligibility Criteria Across Racial/Ethnic Groups.
    Spivey CA; Qiao Y; Wang J; Shih YT; Wan JY; Dagogo-Jack S; Cushman WC; Hines LE; Chisholm-Burns MA
    J Am Geriatr Soc; 2019 Mar; 67(3):581-587. PubMed ID: 30674080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
    Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study.
    Qiao Y; Spivey CA; Wang J; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns MA
    Inquiry; 2018; 55():46958018795749. PubMed ID: 30175638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic Groups.
    Wang J; Qiao Y; Shih YC; Jarrett-Jamison J; Spivey CA; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    J Manag Care Spec Pharm; 2015 Nov; 21(11):993-1003. PubMed ID: 26521111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
    Lee JS; Yang J; Stockl KM; Lew H; Solow BK
    J Manag Care Spec Pharm; 2016 Jan; 22(1):22-30. PubMed ID: 27015048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential health implications of racial and ethnic disparities in meeting MTM eligibility criteria.
    Wang J; Qiao Y; Tina Shih YC; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC
    Res Social Adm Pharm; 2014; 10(1):106-25. PubMed ID: 23759673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.
    Wang J; Brown LM; Hong SH
    J Am Pharm Assoc (2003); 2012; 52(5):e87-96. PubMed ID: 23023863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of medicare part d on disparity implications of medication therapy management eligibility criteria.
    Wang J; Qiao Y; Shih YC; Jamison JJ; Spivey CA; Li L; Wan JY; White-Means SI; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
    Am Health Drug Benefits; 2014 Sep; 7(6):346-58. PubMed ID: 25558303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and ethnic disparities in meeting MTM eligibility criteria among patients with asthma.
    Lu D; Qiao Y; Johnson KC; Wang J
    J Asthma; 2017 Jun; 54(5):504-513. PubMed ID: 27676212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Medicare Part D Medication Therapy Management Eligibility Criteria.
    Wang J; Shih YC; Qin Y; Young T; Thomas Z; Spivey CA; Solomon DK; Chisholm-Burns M
    Am Health Drug Benefits; 2015; 8(5):247-55. PubMed ID: 26380030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparity Implications of Proposed 2015 Medicare Eligibility Criteria for Medication Therapy Management Services.
    Wang J; Qiao Y; Spivey CA; Li C; Clark C; Deng Y; Liu F; Tillman J; Chisholm-Burns M
    J Pharm Health Serv Res; 2016 Dec; 7(4):209-215. PubMed ID: 28025599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should eligibility for medication therapy management be based on drug adherence?
    Stuart B; Loh E; Miller L; Roberto P
    J Manag Care Pharm; 2014 Jan; 20(1):66-75. PubMed ID: 24511767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence.
    Ferries E; Dye JT; Hall B; Ndehi L; Schwab P; Vaccaro J
    J Manag Care Spec Pharm; 2019 Jun; 25(6):688-695. PubMed ID: 31134865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
    Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
    J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Medicare Beneficiary Eligibility for Medication Therapy Management Programs Using PINNACLE, a National Cardiovascular Data Registry.
    Spinler SA; Cziraky MJ; Tang F; Dueñas GG; Thomas T; Reinhold JA; Willey VJ
    Am Health Drug Benefits; 2013 Sep; 6(7):367-74. PubMed ID: 24991369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical trend of disparity implications of Medicare MTM eligibility criteria.
    Wang J; Qiao Y
    Res Social Adm Pharm; 2013; 9(6):758-69. PubMed ID: 23062785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical trend of racial and ethnic disparities in meeting Medicare medication therapy management eligibility in non-Medicare population.
    Wang J; Surbhi S; Zhang Z; Spivey CA; Chisholm-Burns M
    Res Social Adm Pharm; 2014; 10(6):904-917. PubMed ID: 25458405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteria.
    Wang J; Qiao Y; Tina Shih YC; Spivey CA; Dagogo-Jack S; Wan JY; White-Means SI; Cushman WC; Chisholm-Burns MA
    J Pharm Health Serv Res; 2014 Jun; 5(2):109-118. PubMed ID: 25045406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present.
    Gray C; Cooke CE; Brandt N
    Am Health Drug Benefits; 2019 Sep; 12(5):243-251. PubMed ID: 32015791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.